{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:45Z","timestamp":1760057265480,"version":"build-2065373602"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>This study aims to establish a prognostic prediction system for mucosal melanoma patients by integrating melanocyte-targeting PET with clinical parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>A retrospective study was conducted on primary mucosal melanoma patients who underwent [<jats:sup>18<\/jats:sup>F]PFPN PET scans between January 2021 and April 2024. Researchers manually delineated all lesions on the [<jats:sup>18<\/jats:sup>F]PFPN PET images and recorded the imaging features. Kaplan-Meier survival analysis, Cox regression, and stepwise regression were used to analyze prognosis and construct the prediction model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifty patients (mean age 60.5\u00b18.8\u00a0y) were included, with a median follow-up of 13 months (1\u201339\u00a0mo) and an average survival of 14.62 months. Multivariate analysis showed that lower Whole-body Melanotic Tumor Volume (WBMTV), earlier stage, younger age, immunotherapy, and head and neck or vulvar subtypes were associated with longer overall survival (OS, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). A simplified prognostic scoring system was developed based on 5 variables: stage (not detected or I\/II\/III\/IV: 0\/5\/10\/15 points), age (&lt;60\/\u226560: 0\/10), WBMTV (&lt;1.52\/\u22651.52: 0\/10), immunotherapy (yes\/no: 0\/5), and subtype (head and neck or vulva\/others: 0\/10). Patients were stratified into low (0\u201319), intermediate (20-29), and high-risk (30\u201350) groups. The model\u2019s concordance index was 0.85, outperforming the clinical staging (0.76). OS declined progressively from low-risk to high-risk groups, with 1-year survival from 100% to 74.6% and 3-year survival from 100% to 0%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>[<jats:sup>18<\/jats:sup>F]PFPN PET provides an accurate assessment of mucosal melanoma burden, and a prognostic model combining [<jats:sup>18<\/jats:sup>F]PFPN PET features and clinical data offers reliable stratification of patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006117","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T14:00:19Z","timestamp":1757685619000},"page":"1016-1023","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Scoring System Based on [18F]PFPN PET and Clinical Features for Predicting Prognosis in Patients With Mucosal Melanoma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9240-8242","authenticated-orcid":false,"given":"Zhi","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Key Laboratoryof Molecular Imaging"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Key Laboratoryof Molecular Imaging"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2796-5761","authenticated-orcid":false,"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-5240","authenticated-orcid":false,"given":"Yongkang","family":"Gai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-5278","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-7399","authenticated-orcid":false,"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jfma.2023.07.016","article-title":"Clinical practice consensus for the diagnosis and management of melanoma in Taiwan","volume":"123","author":"Wu","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","article-title":"Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis","volume":"21","author":"Kuk","year":"2016","journal-title":"Oncologist"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-018-0675-0","article-title":"Mucosal melanoma: a literature review","volume":"20","author":"Yde","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/imt-2018-0030","article-title":"A study of the clinical characteristics and prognosis of advanced mucosal and cutaneous melanoma in a chinese population","volume":"11","author":"Zhang","year":"2019","journal-title":"Immunotherapy"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00259-020-04757-3","article-title":"Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4","volume":"47","author":"Seban","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"103070","DOI":"10.1016\/j.amjoto.2021.103070","article-title":"Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors","volume":"42","author":"Abt","year":"2021","journal-title":"Am J Otolaryngol"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jdv.16306","article-title":"Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry","volume":"34","author":"Sarac","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1245\/s10434-018-6503-9","article-title":"Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients","volume":"25","author":"Cui","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00405-019-05458-w","article-title":"Current concepts in advanced sinonasal mucosal melanoma: a single institution experience","volume":"276","author":"Meerwein","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2020.04.030","article-title":"Ano-uro-genital mucosal melanoma UK national guidelines","volume":"135","author":"Smith","year":"2020","journal-title":"Eur J Cancer"},{"key":"R11-20251009","first-page":"91","article-title":"Non-cutaneous melanoma, findings and prognostic value of FDG PET\/CT: a case series of 23 patients and review of the literature","volume":"10","author":"Saidi","year":"2022","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"R12-20251009","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-1771280","article-title":"Role of 18F-FDG PET-CT in urethral malignant melanoma and analysis of the UK guidelines on ano-uro-genital melanomas","volume":"22","author":"Mahato","year":"2023","journal-title":"World J Nucl Med"},{"key":"R13-20251009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/wjnm.WJNM_116_20","article-title":"Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in anorectal melanoma","volume":"20","author":"Bakare","year":"2021","journal-title":"World J Nucl Med"},{"key":"R14-20251009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/1450-1147.207274","article-title":"Positron emission tomography in mucosal melanomas of head and neck: results from a south asian tertiary cancer care center","volume":"16","author":"Agrawal","year":"2017","journal-title":"World J Nucl Med"},{"key":"R15-20251009","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/j.semnuclmed.2021.06.010","article-title":"Practical considerations when interpreting FDG PET\/CT imaging for staging and treatment response assessment in melanoma patients","volume":"51","author":"Van de Wiele","year":"2021","journal-title":"Semin Nucl Med"},{"key":"R16-20251009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00259-017-3839-5","article-title":"PET and SPECT imaging of melanoma: state of the art","volume":"45","author":"Wei","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R17-20251009","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.2967\/jnumed.123.266945","article-title":"Melanin-targeting radiotracers and their preclinical, translational, and clinical status: from past to future","volume":"65","author":"Zhang","year":"2024","journal-title":"J Nucl Med"},{"key":"R18-20251009","doi-asserted-by":"crossref","first-page":"107829","DOI":"10.1016\/j.pharmthera.2021.107829","article-title":"Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: preclinical\/clinical development and combination with other treatments","volume":"224","author":"Rouanet","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R19-20251009","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/acs.molpharmaceut.7b00607","article-title":"Synthesis and preclinical evaluation of 18F-PEG3-FPN for the detection of metastatic pigmented melanoma","volume":"14","author":"Xu","year":"2017","journal-title":"Mol Pharm"},{"key":"R20-20251009","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2967\/jnumed.121.263179","article-title":"18F-PFPN PET: A new and attractive imaging modality for patients with malignant melanoma","volume":"63","author":"Zhang","year":"2022","journal-title":"J Nucl Med"},{"key":"R21-20251009","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1007\/s00259-023-06258-5","article-title":"Melanin-targeted [18F]-PFPN PET imaging for prognosticating patients with melanoma","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R22-20251009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.13100","article-title":"Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile","volume":"94","author":"Larsen","year":"2016","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R23-20251009","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R24-20251009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21147\/j.issn.1000-9604.2022.04.02","article-title":"Health Commission of the People\u2019s Republic of China N. National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)","volume":"34","author":"Guo","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"R25-20251009","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1245\/s10434-022-11670-6","article-title":"An evidence-based staging system for mucosal melanoma: a proposal","volume":"29","author":"Cui","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R26-20251009","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hed.24435","article-title":"Localized sinonasal mucosal melanoma: outcomes and associations with stage, radiotherapy and PET response","volume":"38","author":"Samstein","year":"2016","journal-title":"Head & neck"},{"key":"R27-20251009","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s44318-024-00103-7","article-title":"Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification","volume":"43","author":"Parikh","year":"2024","journal-title":"EMBO J"},{"key":"R28-20251009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40257-019-00487-x","article-title":"Malignant melanoma of the vulva and vagina: a US population-based study of 1863 patients","volume":"21","author":"Wohlmuth","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"R29-20251009","doi-asserted-by":"crossref","first-page":"680407","DOI":"10.3389\/fimmu.2021.680407","article-title":"Immunotherapy in acral and mucosal melanoma: current status and future directions","volume":"12","author":"Mao","year":"2021","journal-title":"Front Immunol"},{"key":"R30-20251009","doi-asserted-by":"crossref","first-page":"e29979","DOI":"10.1097\/MD.0000000000029979","article-title":"Immunotherapy as a treatment modality for mucosal melanoma of the head and neck: a systematic review","volume":"101","author":"Wehbe","year":"2022","journal-title":"Medicine"},{"key":"R31-20251009","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12935-021-01927-7","article-title":"A nomogram for predicting survival of head and neck mucosal melanoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:59Z","timestamp":1760025839000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006117","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"2025-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}